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Abstract Carboxy-truncated mutants of human MIF (MIF(1- 
104) and MIF(1-109)) were used in structure activity studies. CD 
spectroscopy revealed an overall structural similarity between the 
mutants and MIF. Denaturant-induced unfolding demonstrated 
that the C-terminus contributed significantly to the conforma- 
tional stability of MIF. This appears to be due to the formation 
of two C-terminal ~-strands. The mutants were enzymatically 
active, exhibiting half of the enzymatic redox activity of MIF. 
However, immunological analysis showed that deletion of both 
5 and 10 C-terminal residues resulted in loss of the macrophage 
activating.properties of MIF, providing functional evidence that 
the C-terminus is important for immunological activity and 
trimer formation. A more detailed study of the C-terminus may 
assist in identifying the molecular basis for the immunological 
and enzymatic activities of MIF. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The classical T cell factor macrophage migration inhibitory 
factor (MIF) was re-defined recently as a pituitary hormone 
and macrophage-derived factor with pro-inflammatory prop- 
erties [14]. The importance of M IF  as T cell cytokine was 
confirmed [5]. M IF  was found to be unique in counter-regu- 
lating the immuno-suppressive and anti-inflammatory effects 
of glucocorticoid hormones [6]. Of  note, MIF  was demon- 
strated to play a critical role in a number of pathologic on- 
ditions such as septic shock, physiological stress, or certain 
immune-mediated diseases [1,(~9]. Several lines of evidence 
indicate that MIF  is one of few cytokines that may act by 
additional enzymatic functions [10 13]. However, the physio- 
logical enzymatic activity of MIF  is not yet known. 
The three-dimensional structure of M IF  was elucidated re- 
cently by X-ray crystallography and NMR methods and MIF  
was found to be a trimer of identical subunits [12,14-17]. 
Each monomer contains two antiparallel c~-helices that pack 
against a four-stranded [3-sheet. In the trimer, the three [3-
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sheets are arranged to form a barrel containing a central sol- 
vent-accessible channel (Fig. 1A). One structural feature that 
has not been characterized precisely is the C-terminal region 
of MIF. In particular, it is not clear if the C-terminus is 
composed of a 13-strand configuration, or if it is structurally 
undefined. For example, no structure was found for the C- 
terminus of rat MIF  [12], whereas for human MIF, none, one, 
or two short C-terminal [3-strand elements have been pro- 
posed [14-17] (Fig. 1B). It has been suggested that the C- 
terminal residues of one monomer interact with residues lo- 
cated within a [3-strand of an adjacent subunit to stabilize the 
trimer [14]. 
Although the elucidated structure of M IF  is unique among 
cytokines and hormones, the barrel-like structural architecture 
of the MIF  protein was found to be highly homologous to 
two bacterial tautomerases [12,18], indicating that trimer for- 
mation may be necessary for the suggested enzymatic activity 
of MIF. To resolve the issue of the C-terminal structure of 
MIF  under solution conditions and because of the proposed 
importance of the carboxy terminus for MIF  trimer stabiliza- 
tion and enzymatic activity, we generated carboxy-truncated 
mutants of human MIF  and performed structure activity 
studies. 
2. Materials and methods 
2.1. Materials 
Miscellaneous chemicals and enzymes were bought from Sigma-Al- 
drich Chemicals (Deisenhofen, Germany) and were of the highest 
grade commercially available. Dye terminator cycle DNA sequencing 
kits were from Perkin Elmer-Applied Biosystems Inc. (ABI) (Weiter- 
stadt, Germany) and plasmids were from Novagen (Madison, WI, 
USA). All other molecular biology reagents including oligonucleotide 
primers were acquired from Gibco BRL (Eggenstein, Germany) or 
New England Biolabs GmbH (Heidelberg, Germany). 
2.2. Site-directed mutagenesis and chining of the carboxy-truncated 
mutants 
Human MIF was amplified originally from Jurkat H33HJ-JA1 T 
cell DNA and cloned into the pET1 lb expression vector as described 
previously [4]. C-terminal deletion mutants of MIF were cloned from 
huMIF-pETllb by DNA amplification. Polymerase chain reactions 
(PCR) were performed in a Perkin Elmer 480 thermocycler (Perkin 
Elmer-ABI). PCR conditions were: 6 min at 94°C followed by 35 
cycles of 70 s at 96°C, 45 s at 50°C, and 30 s at 72°C using 2 units 
of Vent polymerase (New England Biolabs). Primers were designed 
with Ndel (5'-GCT AGC GCA TAT GCC GAT GTT CAT CGT 
AAA CAC-3') and BamHI (5'-CGG GAT CTT TAG TTC CAG 
CCC ACA TTG GCC G-3' and 5'-CGG GAT CCT TAG GCC 
GCG TTC ATG TCG TAA TAG-3' for MIF(1-109) and MIF(I- 
104), respectively) cloning sites and PCR products cloned into the 
NdeI and BamHI sites of pETllb. Mutant DNA sequences were 
confirmed by bidirectional sequencing of the clones using an ABI 
PRISM 377 DNA sequencer (Perkin Elmer-ABI). 
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2.3. Bacterial expression a d purification of the mutant proteins 
Expression and purification of the mutants was performed using a 
slightly modified protocol of that established for wild-type human 
MIF (wtMIF) [4]. Briefly, transformed E. colt BL21 (DE3) containing 
the mutant expression plasmids, were grown at 37°C until the optical 
density at 600 nm reached 0.6 0.8. lsopropyl 1-thio-13-D-galactopyra- 
noside was added to a final concentration of 1 mM and the incubation 
continued for an additional 3 h. Bacteria were harvested by centrifu- 
gation and the cell pellets frozen at -20°C until use. Bacterial pellets 
were resuspended in 3 ml of Tris-buffered saline (30 mM Tris-HCl, 
100 mM NaCI, pH 7.2) and the cells disrupted in a French Press at 
1240 psi. The bacterial extract hen was centrifuged at 38000xg for 
30 min, the supernatant recovered, and sterile-filtered. Purification by 
anion exchange and C8-SepPak reverse-phase chromatography, and 
renaturation of acetonitrile-denatured protein was performed as de- 
scribed previously [4] except that a HQ column (Boehringer Mann- 
heim, Mannheim, Germany) was used for the anion exchange chro- 
matographic separation. Renatured mutants were kept at 4°C until 
use. One mutant, MIF(1-104), was found to aggregate more quickly 
than wtMIF, and thus was not used for longer than 2 weeks after 
renaturation. 
2.4. Biochemical characterization of  the mutants 
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS- 
PAGE) was performed as described [4] and was employed to veri~ 
expression of the mutant proteins. MIF(I-109) migrated at a size of 
approximately 12 kDa and MIF(I-104) was found to have a molec- 
ular weight of about 11.5 kDa (not shown). Size exclusion chroma- 
tography was performed on a Bio-Sil SEC 125-5 column (300x7.8 
mm. Biorad, Munich, Germany) at a flow rate of 1 ml/min using 50 
mM sodium phosphate buffer (pH 7.2) in the presence or absence of 
7 M guanidinium hydrochloride (GdnHC1). Size markers were from 
Biorad and were chromatographed under the same conditions. As 
established previously for wtMIF [4,19], both mutants chromato- 
graphed at a molecular weight of 13 kDa in the presence of GdnHC1 
and at a size of approximately 25 kDa under denaturant-free elution 
conditions. Identity of the mutant proteins was verified further by 
matrix-assisted laser desorption ionization (MALDI) mass spectrom- 
etry using a Kratos Kompact MALDI II1 machine (Shimadzu, Duis- 
burg, Germany). The experimentally determined masses for wtMIF 
(12347 Da), and the mutant proteins MIF(I-109) (11823 Da) and 
M1F(1-104) (1124l Da) were in good agreement with the theoretical, 
predicted MH ~ average mass values of 12346 Da, 11824 Da, and 
11253 Da, respectively. 
2.5. Conjbrmational analysis and structural stability analysis 
Circular dichroism spectropolarimetry (CD) spectra were recorded 
in a J700 spectropolarimeter (Jasco Inc., Tokyo, Japan) that was 
equipped with a thermostated cell holder. The spectra represent the 
average of three scans recorded at 25°C in the range between 195 and 
250 nm and were collected at 0.5 nm intervals with a bandwidth of 
1 nm and a time constant of 8.0 s. Cylindrical quartz cells with a path 
length of I(1 mm were used in all experiments. Final protein concen- 
trations were 1 /aM in 20 mM sodium phosphate buffer (pH 7.2). CD 
spectra are presented as a plot of the mean molar ellipticity per res- 
idue ([O], deg cm ~ dmol l) versus the wavelength. Secondary struc- 
ture analysis of the CD spectra was performed by the computer pro- 
grams CONTIN [20,21], LINCOMB together with the data sets of 
Perczel et al. [22], Yang et ah [23], and Brahms and Brahms [24]. and 
SELCON [25,26]. 
Guandinium hydrochloride (GdnHC1)-induced denaturation studies 
were performed by recording the mean molar ellipticity per residue as 
a function of wavelength (210-250 nm) and GdnHCI concentration as 
described previously [4,27]. Unfolding curves were expressed as the 
percentage of unfolded protein relative to native protein (i.e. the 
change in ellipticity at 222 nm) over the concentration of GdnHC1. 
GdnHCI at concentrations above 3 M did not interfere with the 
measurement a this wavelength. The free energy of unfolding was 
derived from this curve by using the equation: 
AGd = --RTIn((v,~--y)/(y-.v,i)]. 
where y is the ellipticity value at 222 nm and Yn and Y,l are the 
ellipticities at 222 nm for the native and denatured states of the pro- 
tein. respectively. The obtained values for AGd were fitted to the 
equation: 
AGd AGy ~(~ m GdnHC1], 
where AG,y "-° is the value of AGd at zero denaturant concentration and 
m represents he slope of the curve that is a measure of the depend- 
ence of AG,: on the concentration of GdnHC1 [28]. 
2.6. Biological assa.vs 
Enzymatic activity of the mutants was determined by the hydroxy- 
ethyldisulfide (HED) transhydrogenase assay following the method 
described by Holmgren [29] and that was established as an enzymatic 
assay for human MIF (to be published in detail elsewhere) [13]. 
Briefly, reduction of HED by reduced glutathione was measured in 
a MIF-catalyzed reaction. Oxidation of NADPH by oxidized gluta- 
thione was then measured in a coupled step and was recorded spec- 
trophotometrically at a wavelength of 340 nm. Wild-type mouse and 
human MIF were determined to have a specific activity of 420 and 
190 mU, respectively. Carboxy-truncated mutants were tested at the 
conditions established for wtMIF and their enzymatic activities com- 
pared to that of wild-type human MIF. 
Since MIF was recently defined as a cytokine activating macro- 
phages to kill l,eishmania mq/or parasites (Juettner et al., manuscript 
in preparation) the leishmanicidal activity of the MIF mutants was 
tested [30]. Briefly, thioglycolate-elicited routine peritoneal exudate 
cells were washed twice and resuspended in C-RPMI culture medium 
1640 (Biochrom, Berlin, Germany, supplemented with 2 mM L-glu- 
tamine, 10 mM HEPES buffer, 7.5%, NaHCO:~, 0.05 mM 2-ME, 100 
~tg/ml penicillin, 160 ~g/ml gentamycin and 10% selected FCS with a 
total LPS content<600 pg/ml), seeded into Labtek tissue culture 
chambers (2x IO:'/chamber: Flow Laboratories. Meckenheim. Ger- 
many) and were allowed to adhere [or 3 4 h (at 37°C, 5% C()~, 
95% air humidity): thereafter, non-adherent cells were removed by 
three extensive washings with culture medium. Prior to infection, 
macrophage cultures were incubated for 4 h either in culture medium 
alone or in culture medium with t gg/ml of MIF or the MIF mutants. 
Addition of 20 ng/ml interferon-y served as an internal positive con- 
trol. The macrophages were then infected with L. ma/or promastigotes 
(parasite:cell ratio=10:l ) for 4 h in the respective medium. Thereafter, 
non-phagocytosed parasites were washed off', and the cultures were 
further incubated in the respective medium tbr 72 96 h. IntracelJuhH' 
live amastigotes were then assessed after staining with a solution oi 
ethidium bromide (50 gg/ml) and acridine orange (5 ~glml) by fluo- 
rescence microscopy at 450~,90 nm. The percentage of infected mac- 
rophages (infection rate) and the number of parasites/100 infected 
macrophages (mean+_ S.E.M. of 6 observationv, on threc cultures in 
each experiment) were determined. Differences between treated vs. 
control cultures were tested for statistical significance by Student's 
t-test for unpaired samples (two-tailed). 
3. Results 
Two carboxy- t runcated mutants  o f  huMIF  with 5 and 10 
residues deleted, respectively, were constructed by site-directed 
mutagenesis  and expressed in Escherichia colt. The mutants  
were designed to have the putat ive C-terminal  !3-strand(s) 137 
MIF( I -109)  or ~6+137 (MIF( I -104))  deleted (Fig. 1B and C). 
Mutants  were purif ied to homogenei ty  essentially by the meth- 
od used for wtMIF  [4]. Far -UV CD,  which is an excellent 
method  for analyzing the conformat ion  of  proteins in solut ion 
[31], was employed and conf i rmed the overall structural sim- 
ilarity between the mutants  and wtMIF  (Fig. 2A). Detai led 
spectral analysis showed that both wtMIF  and the mutants  
had a broad negative llipticity between 205 and 225 nm and a 
posit ive ellipticity at 197 nm. A l though the spectra were 
a lmost  identical, a small shift towards  shorter  wavelengths 
was seen in the spectra o f  both mutants ,  and was found 
to be consistent  with an increase in random coil conforma-  
tion. Next, quant i f icat ion o f  the secondary structure compo-  
sition of  the mutants  in compar ison  with wtMIF  was per- 
formed by employing a variety o f  computat iona l  
deconvolut ion methods  (Table l). This analysis conf i rmed 
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Fig. 1. Structure of human MIF. A: Architecture of the MIF trimer. The view is along the molecular three-fold axis. B: Ribbon structure of 
the MIF monomer [34]. C: Primary sequence and secondary structure of the MIF monomer. Open arrows indicate 13-strands and cylinders rep- 
resent a-helices. The sites of the deletions are indicated by closed arrows. The putative presence of the C-terminal 13-strands 6 and 7 is ex- 
pressed by question marks. 137 is depicted by a dotted arrow. 
that the solution conformation of  both mutants was very sim- 
ilar to that of wtMIF.  
An increase in random coil structure was predicted by most 
of  the deconvolution methods. According to methods 1-3 and 
5 this increase was caused by deletion of residues 110-114, 
whereas no further increase was seen upon deletion of residues 
105-109. 
The alterations in random coil structure were paralleled by 
a decrease in I~-sheet conformation, when the mutants were 
compared to wtMIF.  Moreover, most deconvolution methods 
(algorithms 1, 3, and 5) predicted that deletion of residues 
109-114 is sufficient for the observed reduction in 13-sheet 
conformation, whereas no further decrease was observed 
when MIF  was truncated at position 104. Of note, deconvo- 
lution by convex constrained analysis using the data set by 
Perczel et al. [22], which is an excellent method to estimate 
antiparallel and parallel 13-sheet components [31], indicated 
that residues 109-114 were in an antiparallel 13-sheet confor- 
mation. Analysis of the [3-turn component by algorithms 2, 3, 
and 5 but not algorithm 4 predicted a decrease in 13-turn 
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Fig. 2. Far-UV CD spectroscopy of wtMIF and the mutants. A: CD spectra of wtMIF, MIF(1-109), and MIF(l-104). CD spectra were re- 
corded at a concentration of 1 gM in 20 mM phosphate buffer, pH 7.2. B: GdnHCl-induced unfolding of wtMIF and MIF(1-109) and 
MIF(1-104). Unfolding curves are expressed as the percentage of unfolded protein relative to native protein (i.e. the change in ellipticity at 222 
nm) over the concentration of GdnHCI. CD spectra and unfolding experiments were performed as described in Section 2. 
structure in the larger mutant ,  with no further decrease seen 
upon delet ion o f  residues 104-109. Analysis o f  the ct-helical 
por t ions  by the various methods  did not  provide conclusive 
data. Overall, no significant alterat ions in a-hel ical  content  
were observed between wtMIF  and the mutants .  
To further investigate the effect o f  the carboxy terminus of  
Table 1 
Quantitative analysis of the secondary structure contents of the mutants in comparison to wild-type MIF  ~ 
Method Secondary structure content (%) 
a-helix !3-sheet Parallel l-sheet Antiparallel t-sheet Parallel l-sheet/l-turn [3-turn Unordered 
1 
wtMIF 13 NA NA 45 22 NA 21 
MIF(l-109) 7 NA NA 27 27 NA 36 
MIF(1-104) 11 NA NA 26 30 NA 34 
2 
wtMIF 25 30 NA NA NA 33 12 
MIF(I-  109) 19 28 NA NA NA 23 30 
MIF(I-104) 22 26 NA NA NA 24 28 
3 
wtMIF 11 50 NA NA NA 15 24 
MIF(I-109) 18 34 NA NA NA 11 38 
MIF(1-104) I 0 43 NA NA NA 9 38 
4 
wtMIF 24 NA 10 20 NA 22 25 
MIF(1-109) 27 NA 6 20 NA 28 24 
MIF(1-104) 30 NA 6 16 NA 26 22 
5 
wtMIF 21 34 NA NA NA 21 24 
MIF(1-109) 25 26 NA NA NA 12 38 
MIF(1 - 104) 28 28 NA NA NA 14 31 
~CD spectra were recorded as described in Section 2. Quantitative analysis of the spectra 
described previously (see Section 2, [4]). 
1, 2, 3: Calculation by the LINCOMB program based on the methods of Perczel et al. 
respectively. 
4, 5: Analysis by the CONTIN [20,21] and SELCON [25,26] computer programs. 
NA: not applicable. 
was performed by various deconvolution methods as 
[22], Yang et al. [23], and Brahms and Brahms [24], 
230 R. Mischke et al./FEBS Letters 414 (1997) 226-232 
A 
. m  
._> 
0 
t"  
o 
8_ 
100 
80 
60 
40 
20 
0 
B 90 
8O 
70 
c- 
O .  60 o 
50 
E 
~ 40 
0 
-- 30 C 
" 20 
O. 
0 
Control IFN-)" wtMIF MIF(1-109) MIF(1-104) 
wtMIF MIF(1-109) MIF(1-104) 
Fig. 3. Biological activity of the mutants in comparison with wtMIF. A: Enzymatic redox assay. The HED transhydrogenase activity of the 
mutants is expressed as percent activity of w MIF. Data represent the mean + S.D. of triplicate experiments. B: Macrophage activating activity 
of the mutants in comparison with wtMIF as determined in a macrophage-dependent Leishmania-killing assay. Activation f macrophages is 
expressed as percent infected macrophages. Control cells were not pretreated with cytokines. Addition of 20 g/ml interferon-y (IFN-y) served 
as a positive control. Data represent the mean _+ S.E.M. of triplicate experiments. Biological assays were performed as described in the experi- 
mental section. 
MIF on trimer stabilization and conformational stability of 
the protein, the mutants were studied by CD together with 
GdnHCl-induced unfolding, and the results compared to the 
effect observed for wtMIF (Fig. 2B). Unfolding was found to 
be cooperative for both wtMIF and the mutants, with the 
midpoints of denaturation estimated to be at a concentration 
of 1.8 M GdnHC1 for wtMIF, and at 1.6 M and 1.5 M for 
MIF(1-109) and MIF(1-104), respectively. The values for the 
free energy of unfolding in the absence of denaturant (AG H2°) 
were determined by linear extrapolation of AGa in the tran- 
sition region [28]. The AG H2° value for MIF(1-109) was sim- 
ilar to that measured for wtMIF (12.51 kJ mol 1 versus 11.9 
kJ mol 1), whereas deletion of 10 C-terminal residues ap- 
peared to markedly reduce protein stability at zero denaturant 
concentration (AG H2° = 8.55 kJ tool -1 for MIF(1-104)). Both, 
the values for the midpoint of denaturation and AGH2° were 
found to be in excellent agreement with previously determined 
values for MIF [4]. 
To examine the effect of carboxy-terminal truncation on the 
functional properties of MIF, the mutant proteins were sub- 
jected to an enzymatic assay and an immunological ssay that 
had been shown previously to be a good measure of the cata- 
lytic and macrophage activating activities of MIF, respectively 
([13], Juettner et al., manuscript in preparation). MIF(1-109) 
showed a 50% reduction in enzymatic redox activity when 
compared to wtMIF. MIF(1-104) also was found to retain 
significant activity (40%) in this test, indicating that the C- 
terminus may not be involved directly in the observed cata- 
lytic activity (Fig. 3A). Finally, the immuno-functional impor- 
tance of the carboxy terminus was studied in a macrophage 
test of Leishmania-killing. When compared to wtMIF and an 
internal positive control, both the larger mutant and the mu- 
tant that was truncated at position 104 did not show any 
remaining enhancement of Leishmania-killing by macrophages 
(Fig. 3B). This indicated that residues 104-114 may be critical 
for the immunological effects of MIF. 
4. Discussion 
Important progress has been made recently in understand- 
ing the biologic role of MIF [1,2,5-9]. These studies howed 
that MIF is an important cytokine that is critically involved in 
the regulation of the host immune and stress responses. With 
respect o the molecular properties, the recent elucidation of 
the three-dimensional structure of MIF [12,14-17] has added 
further to our understanding of the role of MIF. However, 
because a receptor for MIF has not yet been identified and 
because the identity of a catalytic center that is responsible for 
the enzymatic activity of MIF is unclear, the molecular mech- 
anism of MIF action continues to be unknown. 
Important insight into the molecular basis of MIF function 
can be expected from structure activity studies of the C-termi- 
nus of MIF. This region has been proposed to stabilize the 
trimeric structure of the molecule by the formation of hydro- 
gen bonds between subunits [14]. Furthermore, a functional 
role for the C-terminus was suggested when a striking struc- 
tural similarity between MIF and the bacterial enzyme 5-car- 
boxymethyl-2-hydroxymuconate isomerase was discovered 
[12]. However, the precise structure of the carboxy-terminal 
region has not yet been resolved, with the various X-ray struc- 
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tures at variance and differences observed between the X-ray 
crystallographic and NMR data. 
We employed carboxy-truncated mutants of MIF to resolve 
the solution structure of its C-terminus and to study the role 
of this region for the conformational stability and biological 
activity of MIF. Mutants were designed such that in one 
mutant, MIF(1-109), the putative fir-strand was removed, 
and that in the other mutant, MIF(1-104), both the putative 
fi~- and fir-strands were deleted. Hydrogen bonding-mediated 
stabilization of the trimer had been predicted to occur by the 
interaction of the fi6-strand of one subunit with the fi-sheet of 
an adjacent monomer, leading to the appearance of a six- 
stranded fi-sheet per monomer [14]. In another X-ray crystal- 
lographic report [16], it has been suggested that inter-subunit 
interactions in this region are preceded by the formation of an 
intramolecular ntiparallel fi-sheet involving the !36- and fir- 
strands of one monomer. 
Overall, our analysis of the solution structure of the mu- 
tants by CD followed by estimation of the secondary structure 
contents howed that the mutants exhibit a decreased content 
in fi-sheet structure. This was found to be paralleled mainly by 
a concomitant increase in random coil structure, indicating 
that the C-terminal residues contribute towards tertiary struc- 
ture stabilization of MIF. This is in accordance with the crys- 
tallographic analysis of human MIF. Together with the X-ray 
data [16], our results as obtained by algorithms 1, 3, and 5 
suggest that residues 111-113 form a fi-strand in solution. 
Furthermore, deconvolution with these methods indicated 
that while deletion of residues 110 114 led to a loss in fi-sheet 
structure, no further reduction in fi-sheet content occurred, 
when the residues composing the fi6-strand, i.e. 105 108, 
were also deleted. Analysis of the CD spectra by algorithms 
2 and 4 did not confirm this finding. However, methods 1 and 
3 have been demonstrated to better predict the fi-sheet por- 
tions in fi-sheet-rich proteins [31], and the overall significance 
of the changes in structural contents appears to be higher for 
algorithms I, 3, and 5. Only two of the methods allow for the 
differentiation between antiparallel and parallel [3-sheet por- 
tions. Of these, the method by Perczel et al. (algorithm 1), 
which is especially suited for the analysis of fi-sheet contents, 
was found to predict a marked decrease of antiparallel [3-sheet 
structure upon deletion of residues 109-114, but did not re- 
veal any further decrease, when MIF was truncated after res- 
idue 104. Although not confirmed by method 4, our data 
argue for the existence of an intramolecular antiparallel 13- 
sheet within the C-terminal region of MIF. In conclusion, 
the results confirm the existence of the putative fir-strand, 
and together with the evidence collected by Sugimoto et al. 
[16], would suggest hat, in solution, this [3-sheet is formed by 
the C-terminal fi-strands 6 and 7, i.e. residues 105 108 and 
111 113, respectively. 
To determine the stabilizing effect of this structure for the 
trimer, we performed GdnHCl-induced unfolding experiments 
of the mutants. Significant differences in the conformational 
stabilities between the mutants and wtMIF were observed. 
Moreover, the mutants also were found to differ among 
each other. The midpoint of unfolding, which is a good meas- 
ure of the structural stability of proteins, was within the same 
range for wtMIF and the mutants, and was found to be small- 
er than 2 M GdnHC1 with a gradual decrease of stability seen, 
when the ('-terminal region was truncated. As expected from 
AG n,O previous studies on the stability of wtMIF [4], ~l ~ was 
found to be small, i.e. considerably smaller than for most 
globular proteins, for both wtMIF and the mutants. The val- 
ue for MIF(I-109) was similar to that of wtMIF (12.51 kJ 
mol -1  versus 11.90 kJ mol 1), whereas additional deletion of 
residues 105 109 in MIF(I-104) led to a marked drop in 
AG,y 20 (8.55 kJ mol-l). Together, analysis of the conforma- 
tional stability of the mutants indicated that: (a) deletion of 
the entire C-terminus of MIF did not alter the overall stability 
of the protein and (b) deletion of both C-terminal ]3-strands 
led to a small but significant decrease in protein stability. The 
measured conformational stabilities do not readily correlate 
with the proposed deletion of 13-strands. In this regard, one 
would have expected a more pronounced reduction in stability 
for mutant MIF(1-109), as this would lead to elimination of 
the C-terminal fi-sheet. However, deletion of these residues 
may also lead to other molecular interactions that might act 
to over-compensate he assumed fi-strand-related loss in 
stability. Also, it has been suggested that the trimer might 
not be the functional unit of MIF under physiological solu- 
tion conditions ([19,32], Mischke et al., manuscript in prepa- 
ration). Thus, it might be speculated that yet other conforma- 
tions exist that have not been detected by X-ray 
crystallography or NMR, which are methods that both rely 
on the use of highly concentrated, non-physiological, protein 
solutions. We are currently pursuing an experimental ap- 
proach to clarify this point and to further define the contri- 
bution of the C-terminus towards trimerization by covalent 
cross-linking and electrophoretic analysis of wtMIF and the 
C-terminal mutants. 
Both mutants were found to exhibit significant enzymatic 
activity, indicating that C-terminal residues did not participate 
directly in the enzymatic redox activity of MIF. Rather, our 
data suggest hat the observed reduction in enzymatic activity 
may be caused indirectly by the decreased conformational 
stability of the mutants. Because the precise molecular mech- 
anism of the enzymatic redox and tautomerase activities of 
MIF is not known yet, no immediate conclusions can be 
drawn from our studies as to the effect of carboxy-truncation 
on tautomerase activity. 
A macrophage activating activity is well established for 
MIF [2,4,6,33]. In this study, we employed a macrophage- 
based Leishmania-killing assay. In this test, MIF can function 
to enhance macrophage killing of Leishmania parasites in a 
concentration-dependent manner (Juettner et al., manuscript 
in preparation). The assay was employed in this study to 
assess the immunological or cytokine-like activity of the 
MIF mutants. Of note, neither MIF(1-109) nor MIF(I-104) 
exhibited any remaining macrophage activating properties. 
Thus, while no direct dependence of the enzymatic activity 
of MIF on the C-terminus was found, it appears that the C- 
terminal region is critical for MIF-mediated activation of 
macrophages. Because it is likely that these immunological 
activities of MIF occur by a receptor-mediated mechanism, 
our data argue that the C-terminus is involved in receptor 
binding. 
In conclusion, our results suggest hat the C-terminus is an 
important arget for further structure activity studies of MIF. 
More detailed analyses by site-directed mutagenesis will be 
necessary to identify the xact residue or residues that are 
important in this region. Moreover, analysis of the C-terminus 
may assist in identifying the mechanism that may be the mo- 
lecular basis for the immunological nd enzymatic activities of 
232 R. Mischke et al./FEBS Letters 414 (1997) 226-232 
MIF. In addition, our data indicate that C-terminal deletion 
mutants of MIF  could be a valuable tool in the design of 
minimized MIF molecules for potential therapeutic applica- 
tions. 
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